Stig Ogata
COO

Mr. Stig Ogata joined LUCA Science as Chief Operating Officer on March 1st 2024.  Before joining LUCA Science, he served VP, Head of Corporate Communications and Investor Relations from 2018 to 2020, and later as VP, Head of Audit and Supervisory Committee Office. Prior to that, he played a pivotal role in Astellas Pharma US as Senior Director, leading the establishment of Global Marketing Strategy infrastructure, licensing activities and corporate planning.

Mr. Ogata also served as Chief Operating Officer at Polyphenon Pharma in New York, overseeing the setup of a subsidiary focused on developing a botanical-derived drug for the prevention of prostate cancer.